[1]
S. B. Hiremath and P. Gandigawad, “Effects of selective imidazolin-1 receptor agonists’ vs Dihydropyridine calcium channel blockers on insulin resistance in patients of hypertension with metabolic syndrome: a meta-analysis of randomized controlled trials”, Int J Basic Clin Pharmacol, vol. 5, no. 2, pp. 394–401, Dec. 2016.